Neosoma, Inc. is excited to announce that it has received FDA 510(k) clearance for its Brain Mets software medical device. This clearance ushers in a new era in the assessment of brain metastases, ...
StimLabs announces that the U.S. Food & Drug Administration (FDA) has granted 510(k) clearance for Theracor, the first human umbilical cord-derived medical device to be offered in sheet form. This ...
StimLabs announces that the U.S. Food & Drug Administration (FDA) has granted 510(k) clearance for Theracor, the first human umbilical cord-derived medical device to be offered in sheet form. This ...
Next-Generation Novasight Hybrid™ System Submitted to U.S. FDA for 510(k) Clearance U.S. and European Class 1A Guidelines Reinforce Growing ...
Next-Generation Novasight Hybrid System Submitted to U.S. FDA for 510(k) Clearance U.S. and European Class 1A Guidelines Reinforce Growing Adoption of Image-Guided PCIPeer-Reviewed Publications Highli ...
Crescom Co. Ltd., an AI musculoskeletal imaging company, gained U.S. FDA 510(k) clearance Dec. 24 for MediAI-BA, its AI-powered pediatric and adolescent bone age analysis software. Classified as a ...
TipRanks on MSN
Conavi Medical advances hybrid intravascular imaging platform as revenue jumps in fiscal 2025
An update from Conavi Medical ( ($TSE:CNVI) ) is now available. Conavi Medical reported that fiscal 2025 marked a pivotal year, highlighted by the ...
Q4 2025 Earnings Call Transcript December 17, 2025 Operator: Good day, ladies and gentlemen. Welcome to the Fourth Quarter of Fiscal Year 2025 Financial Results Conference Call for NeuroOne Medical ...
Globus Medical went into 2025 with a strong foothold in spine and orthopedics, and it’s well-positioned for the next year. Here are 10 key updates: 1. Globus Medical introduced its DuraPro drill with ...
HeartSciences Inc. (Nasdaq: HSCS) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography ...
5d
Is Weakening Demand And Falling Sales Outlook Altering The Investment Case For ICU Medical (ICUI)?
ICU Medical has recently come under pressure as analysts flagged muted 2.1% annual revenue growth, a projected 7.7% sales decline over the next year, and a contraction in free cash flow margins, ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has increased the size of its private placement previously announced on December 19, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback